Neurocrine Biosciences (NBIX) Share-based Compensation Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.35% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 40.57% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 67.91% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -28.57% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 12.76% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 20.51% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 17.07% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 18.39% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 37.54% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 53.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.76% |
| Dec 31, 2025 | 10.44% |
| Sep 30, 2025 | 7.60% |
| Jun 30, 2025 | 2.17% |
| Mar 31, 2025 | 12.58% |
| Dec 31, 2024 | 23.09% |
| Sep 30, 2024 | 3.81% |
| Jun 30, 2024 | 14.65% |
| Mar 31, 2024 | 10.59% |
| Dec 31, 2023 | 21.97% |
| Sep 30, 2023 | 21.42% |
| Jun 30, 2023 | 32.42% |
| Mar 31, 2023 | 20.51% |
| Dec 31, 2022 | 26.87% |
| Sep 30, 2022 | 28.53% |
| Jun 30, 2022 | 40.36% |
| Mar 31, 2022 | 32.79% |
| Dec 31, 2021 | 38.85% |
| Sep 30, 2021 | 41.59% |
| Jun 30, 2021 | 34.13% |